Skip to main content

Evaluating the Role of Psilocybin Monitors in Psilocybin Therapy for Treatment Resistant Depression: A Pilot Randomized Clinical Trial

Phase: PHASE2 | Sponsor: Centre for Addiction and Mental Health | Compound: Psilocybin

Status
planned
Institution
Centre for Addiction and Mental Health
Start date
2026-04-01
End date
2028-12-01
Registry ID
NCT07211438

View trial record

Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.